Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX) in a report released on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock.

Athersys Price Performance

Shares of Athersys stock opened at $0.00 on Friday. Athersys has a 1-year low of $0.01 and a 1-year high of $1.99. The company’s fifty day simple moving average is $0.01 and its 200-day simple moving average is $0.02. The stock has a market capitalization of $271,563.60, a PE ratio of 0.00 and a beta of -0.90.

Athersys Company Profile

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.